ASIT biotech
Brunelles, Centre, France
About ASIT biotech
ASIT biotech specializes in the research and development of immunotherapeutic products for allergy treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2018)
- Ticker: ebr:ASIT
- Website: asitbiotech.com
- Phone: +32 2 264 03 90
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/asit-biotech-2254034 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.